Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nashan

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 23, 2015
Relevance of chronic hepatitis E in liver transplant recipients: a real-life settingA Galante, S Pischke, S Polywka, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 26, 2006
FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and AustralasiaM Salvadori, K Budde, B Charpentier, et al.
Zeitschrift Fur Gastroenterologie|August 24, 1999
Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphomaA Widjaja, S Wagner, H Mix, et al.
Journal of Hepatology|January 6, 1999
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?K J Oldhafer, A Chavan, N R Frühauf, et al.
Lancet (London, England)|September 18, 2001
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled studyH J Schlitt, A Barkmann, K H Böker, et al.
Transplantation|June 1, 2000
Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetilA Barkmann, B Nashan, H H Schmidt, et al.
Hepatology (Baltimore, Md.)|August 8, 1998
Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infectionH L Tillmann, S Heringlake, C Trautwein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantationH J Schlitt, M Neipp, A Weimann, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 19, 2016
Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantationS Ciesek, V Proske, B Otto, et al.
Transplantation Proceedings|December 20, 2007
Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapyJ R Chapman, H Valantine, J Albanell, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 23, 2015
Relevance of chronic hepatitis E in liver transplant recipients: a real-life settingA Galante, S Pischke, S Polywka, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 26, 2006
FTY720 versus MMF with cyclosporine in de novo renal transplantation: a 1-year, randomized controlled trial in Europe and AustralasiaM Salvadori, K Budde, B Charpentier, et al.
Zeitschrift Fur Gastroenterologie|August 24, 1999
Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphomaA Widjaja, S Wagner, H Mix, et al.
Journal of Hepatology|January 6, 1999
Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?K J Oldhafer, A Chavan, N R Frühauf, et al.
Lancet (London, England)|September 18, 2001
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled studyH J Schlitt, A Barkmann, K H Böker, et al.
Transplantation|June 1, 2000
Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetilA Barkmann, B Nashan, H H Schmidt, et al.
Hepatology (Baltimore, Md.)|August 8, 1998
Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infectionH L Tillmann, S Heringlake, C Trautwein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantationH J Schlitt, M Neipp, A Weimann, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 19, 2016
Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantationS Ciesek, V Proske, B Otto, et al.
Transplantation Proceedings|December 20, 2007
Proliferation signal inhibitors in transplantation: questions at the cutting edge of everolimus therapyJ R Chapman, H Valantine, J Albanell, et al.
Pageof 13